MAPT and Alzheimer disease: To further confirm that BACE1 and γ-secretase inhibitors were decreasing insoluble tau, additional studies were conducted in which the amount of rat tau within soluble and insoluble fractions from AD-tau-treated neuronal culture homogenates was assessed by immunoblotting.